Publicly funded chemotherapy clinics in NZ have increased 25% in two years, to just over 57,000 outpatient sessions in public hospitals in the 2009/10 year, says Health Minister Tony Ryall. READ MORE>
Posted in Chemotherapy | Tagged catheter, chemotherapy sessions, Health Minister Tony Ryall, NZ cancer treatment stats, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment | Leave a Comment »
REUTERS: British scientists say they have developed a lab test that can accurately distinguish prostate cancer from healthy tissue and other prostate conditions. READ MORE>
Researchers at a genetics and diagnostics firm Oxford Gene Technology say the set of biological signals, or biomarkers, they have identified was able to distinguish healthy tissue and benign prostate disease from prostate cancer with 90 percent accuracy in initial laboratory sample tests.
A full test for use in doctors’ clinics is likely to be at least five years off, they said, but their pilot study testing around 130 samples showed encouraging results in a disease area where more accurate diagnostic tests are sorely needed.
Posted in New tests | Tagged biological signals, Biomarkers, cancer research, catheter, diagnostic tests, lab test, Oxford Gene Technology, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, REUTERS, Screening debate | Leave a Comment »
HEALTH NEWS TODAY: When combined with the erectile-dysfunction drug Viagra, a long-used chemotherapy drug called doxorubicin may be even more effective as a treatment for prostate cancer, according to a new study. READ MORE>
Posted in Chemotherapy, Erectile function, Treatment news | Tagged cancer research, catheter, Erectile function, erectile-dysfunction drug Viagra, HEALTH NEWS TODAY, hemotherapy drug, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment | 2 Comments »
WASHINGTON EXAMINER.COM: Here’s a well-written article on the current US debate about how much a life is worth – more specifically, how much the government Medicare scheme and health insurers pay out for cancer drugs that prolong life for a few months. READ MORE>
Posted in Provenge, Treatment debate | Tagged cancer drugs, health insurers, life is worth, Medicare, prolong life, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment debate, Provenge treatment, US debate, WASHINGTON EXAMINER.COM | 2 Comments »